Codiak BioSciences, Inc. Deferred Offering Costs
Codiak BioSciences, Inc. had Deferred Offering Costs of $200.00 thousand as of 2021-12-31, per its 10-K filed 2022-03-10.
Discontinued › Balance Sheet › Assets › Assets, Current
us-gaap:DeferredOfferingCosts · last filed 2022-03-10
- 2021-12-31: Deferred Offering Costs $200.00K.
- 2020-12-31: Deferred Offering Costs $200.00K.
- 2020-09-30: Deferred Offering Costs $1.66M.
- 2019-12-31: Deferred Offering Costs $0.00.
| Period end | Deferred Offering Costs |
|---|---|
| 2021-12-31 | $200.00K 10-K · filed 2022-03-10 |
| 2020-12-31 | $200.00K 10-K · filed 2022-03-10 |
| 2020-09-30 | $1.66M 10-Q · filed 2020-11-19 |
| 2019-12-31 | $0.00 10-K · filed 2021-03-17 |
| 2019-09-30 | $0.00 10-Q · filed 2020-11-19 |